Related Experiment Video
Updated: Mar 3, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic
İbrahim Gökçe1, Neslihan Çiçek1, Serçin Güven1
1Department of Pediatrics, Division of Pediatric Nephrology, Marmara University School of Medicine, İstanbul, Turkey.
Insights
Antibiotic resistance in childhood urinary tract infections (UTIs) is increasing for some drugs like cefixime and ciprofloxacin. Periodic evaluation of resistance patterns is crucial for effective empiric antimicrobial therapy in pediatric UTIs.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Urinary tract infections (UTIs) are common in children, with causative agent spectrum and antibiotic resistance patterns influenced by various factors.
- Understanding these patterns is essential for effective treatment and public health strategies.
Purpose of the Study:
- To analyze antibiotic resistance trends in pediatric UTIs over time.
- To compare current resistance patterns with historical data to identify changes.
Main Methods:
- Retrospective cross-sectional study analyzing Gram-negative bacteria from pediatric UTIs.
- Comparison of antibiotic resistance data from 2001-2003 (period 1) and 2011-2014 (period 2).
Main Results:
- Escherichia coli remained the predominant pathogen (60-73%).
- Significant increasing resistance trends observed for cefixime (1% to 15%), amikacin (0% to 4%), and ciprofloxacin (0% to 3%).
- Decreasing resistance trend noted for nitrofurantoin (17% to 7%).
Conclusions:
- Antibiotic resistance in pediatric UTIs necessitates periodic evaluation.
- Empiric antimicrobial therapy decisions should be guided by current antibiotic sensitivity results.
Background:
The causative agent spectrum and resistance patterns of urinary tract infections in children are affected by many factors.
Aims:
To demonstrate antibiotic resistance in urinary tract infections and changing ratio in antibiotic resistance by years.
Study Design:
Retrospective cross-sectional study.
Methods:
We analysed antibiotic resistance patterns of isolated Gram (-) bacteria during the years 2011-2014 (study period 2) in children with urinary tract infections. We compared these findings with data collected in the same centre in 2001-2003 (study period 1).
Results:
Four hundred and sixty-five uncomplicated community-acquired Gram (-) urinary tract infections were analysed from 2001-2003 and 400 from 2011-2014. Sixty-one percent of patients were female (1.5 girls : 1 boy). The mean age of children included in the study was 3 years and 9 months. Escherichia coli was the predominant bacteria isolated during both periods of the study (60% in study period 1 and 73% in study period 2). Bacteria other than E. coli demonstrated a higher level of resistance to all of the antimicrobials except trimethoprim-sulfamethoxazole than E. coli bacteria during the years 2011-2014. In our study, we found increasing resistance trends of urinary pathogens for cefixime (from 1% to 15%, p<0.05), amikacin (from 0% to 4%, p<0.05) and ciprofloxacin (from 0% to 3%, p<0.05) between the two periods. Urinary pathogens showed a decreasing trend for nitrofurantoin (from 17% to 7%, p=0.0001). No significant trends were detected for ampicillin (from 69% to 71%), amoxicillin-clavulanate (from 44% to 43%), cefazolin (from 39% to 32%), trimethoprim-sulfamethoxazole (from 32% to 31%), cefuroxime (from 21% to 18%) and ceftriaxone (from 10% to 14%) between the two periods (p>0.05).
Conclusion:
In childhood urinary tract infections, antibiotic resistance should be evaluated periodically and empiric antimicrobial therapy should be decided according to antibiotic sensitivity results.
More Related Videos
Related Concept Videos
Urine Studies II: Urine Culture and Sensitivity Test
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Antibiotic Resistance
Urinary Tract Infection II: Pathophysiology

